Seregni E - Search Results

1

Individualized dosimetry in the management of metastatic differentiated thyroid cancer.

Chiesa C, Castellani MR, Vellani C, Orunesu E, Negri A, Azzeroni R, Botta F, Maccauro M, Aliberti G, Seregni E, Lassmann M, Bombardieri E. Chiesa C, et al. Among authors: seregni e. Q J Nucl Med Mol Imaging. 2009 Oct;53(5):546-61. Q J Nucl Med Mol Imaging. 2009. PMID: 19910908 Free article. Clinical Trial.

2

The role of serum carcinoembryonic antigen (CEA) in the management of patients with colorectal carcinoma: the experience of the Istituto Tumori of Milan.

Seregni E, Bombardieri E, Bogni A, Crippa F, De Jager E, Buraggi GL. Seregni E, et al. Int J Biol Markers. 1992 Jul-Sep;7(3):167-70. doi: 10.1177/172460089200700308. Int J Biol Markers. 1992. PMID: 1431340

3

Pilot, multicenter and prospective trials with an anti-CEA antibody.

Buraggi GL, Gasparini M, Seregni E, Bombardieri E, Regalia E, Maffioli L. Buraggi GL, et al. Among authors: seregni e. Int J Biol Markers. 1992 Jul-Sep;7(3):189-92. doi: 10.1177/172460089200700312. Int J Biol Markers. 1992. PMID: 1431344 Clinical Trial.

4

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases.

Bombardieri E, Pizzichetta M, Veronesi P, Seregni E, Bogni A, Maffioli L, Jotti GS, Bassetto MA, Zurrida S, Costa A. Bombardieri E, et al. Among authors: seregni e. Eur J Cancer. 1992;29A(1):144-6. doi: 10.1016/0959-8049(93)90595-7. Eur J Cancer. 1992. PMID: 1445733

5

Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.

Crippa F, Bombardieri E, Seregni E, Castellani MR, Gasparini M, Maffioli L, Pizzichetta M, Buraggi GL. Crippa F, et al. Among authors: seregni e. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):52-5. J Nucl Biol Med (1991). 1992. PMID: 1450226

6

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.

Colombo C, Castellani MR, Balistreri WF, Seregni E, Assaisso ML, Giunta A. Colombo C, et al. Among authors: seregni e. Hepatology. 1992 Apr;15(4):677-84. doi: 10.1002/hep.1840150421. Hepatology. 1992. PMID: 1551646

7

Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEA.

Boccardo F, Bombardieri E, Zanardi S, Valenti G, Zanaboni F, Valtolina M, Seregni E, Crippa F. Boccardo F, et al. Among authors: seregni e. Int J Biol Markers. 1991 Jan-Mar;6(1):12-20. doi: 10.1177/172460089100600103. Int J Biol Markers. 1991. PMID: 1856512

8

Mucinic tumor markers recognized by monoclonal antibodies.

Seregni E, Bombardieri E, Maffioli L, Buraggi GL. Seregni E, et al. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4):314-20. J Nucl Med Allied Sci. 1990. PMID: 2090797 Review. No abstract available.

9

Alpha-fetoprotein (AFP) in germ cell tumors of the testis.

Seregni E, Savelli G, Bombardieri E. Seregni E, et al. J Nucl Med Allied Sci. 1989 Jul-Sep;33(3 Suppl):42-5. J Nucl Med Allied Sci. 1989. PMID: 2480421 Review. No abstract available.

10

Radioimmunodetection of melanoma: preliminary results of a prospective study.

Buraggi G, Turrin A, Cascinelli N, Attili A, Gasparini M, Callegaro L, Ferrone S, Seregni E, Bombardieri E, Belli F. Buraggi G, et al. Among authors: seregni e. Int J Biol Markers. 1986 Jan-Apr;1(1):47-54. doi: 10.1177/172460088600100108. Int J Biol Markers. 1986. PMID: 2826619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters